Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study

Bibliographic Details
Published in:	Blood Cancer Journal
Main Authors:	Niels W. C. J. van de Donk, Nizar Bahlis, Luciano J. Costa, María-Victoria Mateos, Ajay K. Nooka, Aurore Perrot, Alfred L. Garfall, Pragya Thaman, Keqin Qi, Clarissa Uhlar, Katherine Chastain, Margaret Doyle, Saad Z. Usmani
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-10-01
Online Access:	https://doi.org/10.1038/s41408-024-01160-1

Internet